Dawn Heckathorn
Family · Nappanee, INNPI 1891223038
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $944 and has fallen 93.8% since, to $59 in 2023.
Across 97 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$276
- Novo Nordisk$269
- Amgen$235
- Sunovion Pharmaceuticals Inc.$133
- Biohaven Pharmaceutical Holding Company Ltd.$105
- Johnson & Johnson$103
- plus $612 from 17 others
What the payments were for
- Food & beverage$1,733100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $276 |
| Novo Nordisk | 17 | $269 |
| Amgen | 13 | $235 |
| Sunovion Pharmaceuticals Inc. | 9 | $133 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $105 |
| Johnson & Johnson | 5 | $103 |
| Bayer | 4 | $91 |
| Pfizer | 4 | $77 |
| Boehringer Ingelheim | 2 | $56 |
| Lilly USA, LLC | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 3 | $37 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| GSK | 2 | $31 |
| Sanofi Pasteur Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Boston Scientific | 1 | $22 |
| AstraZeneca | 1 | $22 |
| Genentech USA, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
How this compares
$1,733 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.
Other family in Nappanee
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.